Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 705.00
Bid: 697.00
Ask: 722.00
Change: 0.00 (0.00%)
Spread: 25.00 (3.587%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 705.00
HSBA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement on the BoE 2018 Stress Test Results

28 Nov 2018 17:35

RNS Number : 8237I
HSBC Holdings PLC
28 November 2018
 

 

 

STATEMENT ON THE BANK OF ENGLAND

2018 STRESS TEST RESULTS

 

 

HSBC Holdings plc ('HSBC') notes the publication today of the results of the Bank of England's 2018 concurrent stress test. The Bank of England's results show that, under the hypothetical annual cyclical stress scenario, HSBC's common equity tier 1 ('CET1') capital ratio on an IFRS 9 transitional basis1 would fall to a low point of 9.1%, above HSBC's CET1 hurdle rate of 7.8%.

 

On an IFRS 9 non-transitional basis, HSBC's CET1 capital ratio is projected to reach a low point of 8.2% which is above HSBC's IFRS 9 non-transitional CET1 hurdle rate of 6.6%.

 

The Bank of England applied the same stresses in the 2018 annual cyclical scenario as used in the 2017 exercise. Using the same scenario has allowed the Bank of England to isolate the impact on the stress test results of the introduction of IFRS 9 in 2018. The scenario modelled a hypothetical synchronised global downturn with growth in Hong Kong and China and other emerging market economies in which HSBC operates being particularly adversely affected. The scenario also incorporated a rise in the UK bank rate to 4% and a sharp depreciation of sterling.

 

Today's results demonstrate HSBC's continued capital strength under this severe scenario.

 

The results incorporate strategic management actions, including CRD IV restrictions, which have been accepted by the Bank of England for the purposes of this exercise. Under adverse economic circumstances, we would in practice consider a variety of management actions depending on the particular prevailing circumstances. Our intention, as evidenced by past actions, is to maintain a conservative and prudent stance on capital management.

 

The Bank of England's 2018 stress test results are available to view in full on the Bank of England's website at: https://www.bankofengland.co.uk/news.

 

 

 

 

 

HSBC's results under the annual cyclical scenario are shown below.

 

 

 

 

Minimum stressed ratio after 'strategic' management actions and before conversion of AT1

 

 

 

 

Actual

(end-2017)(j)

Minimum stressed ratio (before 'strategic' management actions or AT1 conversions)

Non-dividend 'strategic' management actions only(i)

All 'strategic' management actions including CRD IV related restrictions

Minimum stressed ratio (after the impact of 'strategic' management actions and conversion of AT1)

Hurdle rate

Actual (2018 Q3)

IFRS 9 Transitional

 

 

 

 

 

 

 

Common equity tier 1 ratio(a) (b)

14.6%

5.8%

6.4%

9.1%

9.1%

7.8%

14.3%

Tier 1 capital ratio(c)

17.4%

7.7%(g)

8.5%(g)

11.1%(g)

11.1%(g)

 

17.3%

Total capital ratio(d)

21.0%

10.0%(g)

11.0%(g)

13.6%(g)

13.6%(g)

 

20.7%

Memo: risk weighted assets (US$ billion)

872

1,118(g)

1,039(g)

1,041(g)

1,041(g)

 

863

Memo: CET1 (US$ billion)

127

65(g)

67(g)

95(g)

95(g)

 

123

Tier 1 leverage ratio(a) (e)

6.1%

3.9%

4.0%

4.6%

4.6%

3.75%

5.9%

Memo: leverage exposure (US$ billion)

2,346

2,284(h)

2,239(h)

2,241(h)

2,241(h)

 

2,448

IFRS 9 Non-transitional

 

 

 

 

 

 

 

Common equity tier 1 ratio(f)

14.5%

6.3%

6.7%

8.2%

8.2%

6.6%

14.2%

Tier 1 leverage ratio(f)

6.1%

3.5%

3.6%

4.2%

4.2%

3.34%

5.9%

 

Sources: HSBC's published accounts and STDF submissions, Bank of England analysis and calculations.

 

(a) The low points for the common equity tier 1 (CET1) ratio and leverage ratio shown in the table do not necessarily occur in the same year of the stress scenario and correspond to the year where the minimum stressed ratio is calculated after 'strategic' management actions and before AT1 conversion.

(b) The CET1 capital ratio is defined as CET1 capital expressed as a percentage of risk-weighted assets, where these are in line with CRR and the UK implementation of CRD IV via the PRA Rulebook.

(c) Tier 1 capital ratio is defined as tier 1 capital expressed as a percentage of RWAs where tier 1 capital is defined as the sum of CET1 capital and additional tier 1 capital in line with the UK implementation of CRD IV.

(d) Total capital ratio is defined as total capital expressed as a percentage of RWAs where total capital is defined as the sum of tier 1 capital and tier 2 capital in line with the UK implementation of CRD IV.

(e) The tier 1 leverage ratio is tier 1 capital expressed as a percentage of the leverage exposure measure excluding central bank reserves, in line with the PRA's Policy Statement PS21/17.

(f) The low point year on a non-transitional IFRS 9 basis may differ to the low point year on a transitional IFRS 9 basis. Non-transitional IFRS 9 hurdle rates are hypothetical. The Bank will review its method for calculating these hurdle rates in future years.

(g) Corresponds to the same year as the minimum CET1 ratio over the stress scenario after 'strategic' management actions.

(h) Corresponds to the same year as the minimum leverage ratio over the stress scenario after 'strategic' management actions.

(i) This excludes CRD IV distribution restrictions. Where a bank is subject to such restrictions all non business as usual cuts to distributions subject to CRD IV restrictions will appear in the next column - 'All 'strategic' management actions including CRD IV distribution restrictions'. This should not be interpreted as a judgement by the Bank that any or all of such cuts are conditional on such restrictions.

(j) Actuals for end-2017 are shown on the basis of 1 January 2018 in order to incorporate the implementation of IFRS 9.

 

 

 

Investor enquiries to:Richard O'Connor +44 (0) 20 7991 6590 richard.j.oconnor@hsbc.com

Mark Phin +44 (0) 20 7992 6923 mark.j.phin@hsbc.com

 

Media enquiries to:Heidi Ashley +44 (0) 20 7992 2045 heidi.ashley@hsbc.com

Ankit Patel +44 (0) 20 7991 9813 ankit.patel@hsbc.com

 

 

Footnote:

 

1HSBC's CET1 ratio on a transitional basis is calculated using the EU's regulatory transitional arrangements for IFRS 9 in article 473a of the Capital Requirements Regulation.

 

 

Note to editors:

 

HSBC Holdings plc

HSBC Holdings plc, the parent company of the HSBC Group, is headquartered in London. The Group serves customers worldwide from around 3,800 offices in 66 countries and territories in Europe, Asia, North and Latin America, and the Middle East and North Africa. With assets of US$2,603bn at 30 September 2018, HSBC is one of the world's largest banking and financial services organisations.

 

 

ends/all

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFKFDDOBDDADB
Date   Source Headline
14th Mar 20246:07 pmRNSTransaction in Own Shares
14th Mar 20245:02 pmRNSDirector/PDMR Shareholding
13th Mar 20246:20 pmRNSTransaction in Own Shares
13th Mar 20244:00 pmRNSDirector/PDMR Shareholding
12th Mar 20246:06 pmRNSTransaction in Own Shares
12th Mar 202411:00 amRNSIssuance of subordinated unsecured notes
11th Mar 20245:56 pmRNSTransaction in Own Shares
8th Mar 20246:19 pmRNSTransaction in Own Shares
7th Mar 20246:05 pmRNSTransaction in Own Shares
6th Mar 20245:57 pmRNSTransaction in Own Shares
5th Mar 20245:48 pmRNSTransaction in Own Shares
4th Mar 20245:55 pmRNSTransaction in Own Shares
4th Mar 20243:30 pmRNSIssuance of senior unsecured notes
1st Mar 20246:02 pmRNSTransaction in Own Shares
29th Feb 20245:52 pmRNSTransaction in Own Shares
29th Feb 20244:31 pmRNSDirector/PDMR Shareholding
29th Feb 20244:30 pmRNSTotal Voting Rights
28th Feb 20245:55 pmRNSTransaction in Own Shares
28th Feb 202411:01 amRNSDirector/PDMR Shareholding
28th Feb 202411:00 amRNSOverseas Regulatory Announcement - Grant of Awards
27th Feb 20245:56 pmRNSTransaction in Own Shares
26th Feb 20245:50 pmRNSTransaction in Own Shares
23rd Feb 20246:05 pmRNSTransaction in Own Shares
23rd Feb 20244:35 pmRNSDocuments available at NSM
23rd Feb 20244:20 pmRNSPublication of base prospectus supplement
22nd Feb 20244:30 pmRNSTotal Voting Rights
22nd Feb 202410:30 amRNSHSBC Holdings PLC – Share buy-back
21st Feb 20244:35 pmRNSDocuments Available at NSM
21st Feb 20244:31 pmRNSAnnual Financial Report - Part 12
21st Feb 20244:31 pmRNSAnnual Financial Report - Part 11
21st Feb 20244:31 pmRNSAnnual Financial Report - Part 10
21st Feb 20244:31 pmRNSAnnual Financial Report - Part 9
21st Feb 20244:31 pmRNSAnnual Financial Report - Part 8
21st Feb 20244:31 pmRNSAnnual Financial Report - Part 7
21st Feb 20244:31 pmRNSAnnual Financial Report - Part 6
21st Feb 20244:31 pmRNSAnnual Financial Report - Part 5
21st Feb 20244:31 pmRNSAnnual Financial Report - Part 4
21st Feb 20244:31 pmRNSAnnual Financial Report - Part 3
21st Feb 20244:31 pmRNSAnnual Financial Report - Part 2
21st Feb 20244:31 pmRNSAnnual Financial Report - Part 1
21st Feb 20247:00 amRNS2023 Results - webcast presentation
21st Feb 20247:00 amRNSHSBC Holdings 2023 Results
16th Feb 20244:30 pmRNSTransaction in Own Shares & Conclusion of Buy-Back
15th Feb 20244:45 pmRNSTransaction in Own Shares
14th Feb 20244:30 pmRNSTransaction in Own Shares
9th Feb 20244:31 pmRNSTransaction in Own Shares
8th Feb 20244:30 pmRNSTransaction in Own Shares
7th Feb 20244:35 pmRNSTransaction in Own Shares
7th Feb 202410:00 amRNSOverseas Regulatory Announcement - Board Meeting
6th Feb 20244:30 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.